Wednesday, January 18, 2017

British Journal of Cancer - Table of Contents alert Volume 116 Issue 2

If you are unable to see the message below, click here to view.
British Journal of Cancer

Advertisement
nature.com webcasts

Springer Nature presents a custom webcast on: Liquid biopsy: CTC-based classifier predicts chemo resistance in lung cancer

Date: Thursday January 19 2017
Time: 8AM PST, 11AM EST, 4PM GMT, 5PM CET 

Register for FREE

Sponsored by: 
Menarini Silicon Biosystems
 

TABLE OF CONTENTS

Volume 116, Issue 2 (149-276)
Published online 17 January 2017

In this issue
Minireviews
Clinical Studies
Molecular Diagnostics
Epidemiology

Also new today
Advance online publication
Digital Edition
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe

Minireviews

Top

The p53 family orchestrates the regulation of metabolism: physiological regulation and implications for cancer therapy

Marco Napoli and Elsa R Flores

Br J Cancer 2017 116: 149-155; advance online publication, November 24, 2016; 10.1038/bjc.2016.384

Abstract | Full Text

Biomarkers in anal cancer: from biological understanding to stratified treatment

Christopher M Jones, Vicky Goh, David Sebag-Montefiore and Duncan C Gilbert

Br J Cancer 2017 116: 156-162; advance online publication, December 6, 2016; 10.1038/bjc.2016.398

Abstract | Full Text

Clinical Studies

Top

Childhood neuroendocrine tumours: a descriptive study revealing clues for genetic predisposition

I J Diets, I D Nagtegaal, J Loeffen, I de Blaauw, E Waanders, N Hoogerbrugge and M C J Jongmans

Br J Cancer 2017 116: 163-168; advance online publication, December 13, 2016; 10.1038/bjc.2016.408

Abstract | Full Text

Organ preservation with local excision or active surveillance following chemoradiotherapy for rectal cancer

B Creavin, E Ryan, S T Martin, A Hanly, P R O'Connell, K Sheahan and D C Winter

Br J Cancer 2017 116: 169-174; advance online publication, December 20, 2016; 10.1038/bjc.2016.417

Abstract | Full Text

EGFR mutation detection in circulating cell-free DNA of lung adenocarcinoma patients: analysis of LUX-Lung 3 and 6

Yi-Long Wu, Lecia V Sequist, Cheng-Ping Hu, Jifeng Feng, Shun Lu, Yunchao Huang, Wei Li, Mei Hou, Martin Schuler, Tony Mok, Nobuyuki Yamamoto, Kenneth O'Byrne, Vera Hirsh, Neil Gibson, Dan Massey, Miyoung Kim and James Chih-Hsin Yang

Br J Cancer 2017 116: 175-185; advance online publication, December 22, 2016; 10.1038/bjc.2016.420

Abstract | Full Text

Molecular Diagnostics

Top

Prognostic impact of CD44-positive cancer stem-like cells at the invasive front of gastric cancer

Hirokazu Kodama, Satoshi Murata, Mitsuaki Ishida, Hiroshi Yamamoto, Tsuyoshi Yamaguchi, Sachiko Kaida, Tohru Miyake, Katsushi Takebayashi, Ryoji Kushima and Masaji Tani

Br J Cancer 2017 116: 186-194; advance online publication, December 8, 2016; 10.1038/bjc.2016.401

Abstract | Full Text

Perivascular PDGFR-β is an independent marker for prognosis in renal cell carcinoma

Magnus Frödin, Artur Mezheyeuski, Sara Corvigno, Ulrika Harmenberg, Per Sandström, Lars Egevad, Martin Johansson and Arne Östman

Br J Cancer 2017 116: 195-201; advance online publication, December 8, 2016; 10.1038/bjc.2016.407

Abstract | Full Text

Increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of bladder cancer

Barbara Pardini, Clara Viberti, Alessio Naccarati, Alessandra Allione, Marco Oderda, Rossana Critelli, Mirko Preto, Andrea Zijno, Giuseppina Cucchiarale, Paolo Gontero, Paolo Vineis, Carlotta Sacerdote and Giuseppe Matullo

Br J Cancer 2017 116: 202-210; advance online publication, December 13, 2016; 10.1038/bjc.2016.411

Abstract | Full Text

Breast cancer in neurofibromatosis type 1: overrepresentation of unfavourable prognostic factors

Elina Uusitalo, Roope A Kallionpää, Samu Kurki, Matti Rantanen, Janne Pitkäniemi, Pauliina Kronqvist, Pirkko Härkönen, Riikka Huovinen, Olli Carpen, Minna Pöyhönen, Sirkku Peltonen and Juha Peltonen

Br J Cancer 2017 116: 211-217; advance online publication, December 8, 2016; 10.1038/bjc.2016.403

Abstract | Full Text

Overexpression of PBK/TOPK relates to tumour malignant potential and poor outcome of gastric carcinoma

Takuma Ohashi, Shuhei Komatsu, Daisuke Ichikawa, Mahito Miyamae, Wataru Okajima, Taisuke Imamura, Jun Kiuchi, Toshiyuki Kosuga, Hirotaka Konishi, Atsushi Shiozaki, Hitoshi Fujiwara, Kazuma Okamoto, Hitoshi Tsuda and Eigo Otsuji

Br J Cancer 2017 116: 218-226; advance online publication, November 29, 2016; 10.1038/bjc.2016.394

Abstract | Full Text

Tumour-derived alkaline phosphatase regulates tumour growth, epithelial plasticity and disease-free survival in metastatic prostate cancer

S R Rao, A E Snaith, D Marino, X Cheng, S T Lwin, I R Orriss, F C Hamdy and C M Edwards

Br J Cancer 2017 116: 227-236; advance online publication, December 22, 2016; 10.1038/bjc.2016.402

Abstract | Full Text

Crowdsourcing for translational research: analysis of biomarker expression using cancer microarrays

Jonathan Lawson, Rupesh J Robinson-Vyas, Janette P McQuillan, Andy Paterson, Sarah Christie, Matthew Kidza-Griffiths, Leigh-Anne McDuffus, Karwan A Moutasim, Emily C Shaw, Anne E Kiltie, William J Howat, Andrew M Hanby, Gareth J Thomas and Peter Smittenaar

Br J Cancer 2017 116: 237-245; advance online publication, December 13, 2016; 10.1038/bjc.2016.404

Abstract | Full Text

Epidemiology

Top

Effect of population breast screening on breast cancer mortality up to 2005 in England and Wales: an individual-level cohort study

Louise E Johns, Derek A Coleman, Anthony J Swerdlow and Susan M Moss

Br J Cancer 2017 116: 246-252; advance online publication, December 8, 2016; 10.1038/bjc.2016.415

Abstract | Full Text

Interval cancers after skin cancer screening: incidence, tumour characteristics and risk factors for cutaneous melanoma

J Hübner, A Waldmann, A C Geller, M A Weinstock, N Eisemann, M Noftz, S Bertram, S Nolte, B Volkmer, R Greinert, E Breitbart and A Katalinic

Br J Cancer 2017 116: 253-259; advance online publication, November 29, 2016; 10.1038/bjc.2016.390

Abstract | Full Text

History of chronic inflammatory disorders increases the risk of Merkel cell carcinoma, but does not correlate with Merkel cell polyomavirus infection

Helka Sahi, Harri Sihto, Miia Artama, Virve Koljonen, Tom Böhling and Eero Pukkala

Br J Cancer 2017 116: 260-264; advance online publication, December 15, 2016; 10.1038/bjc.2016.391

Abstract | Full Text

Combined oral contraceptive use before the first birth and epithelial ovarian cancer risk

Linda S Cook, Claire R Pestak, Andy CY Leung, Helen Steed, Jill Nation, Kenneth Swenerton, Richard Gallagher, Anthony Magliocco, Martin Köbel, Angela Brooks-Wilson and Nhu Le

Br J Cancer 2017 116: 265-269; advance online publication, December 13, 2016; 10.1038/bjc.2016.400

Abstract | Full Text

Smoking and risk of ovarian cancer by histological subtypes: an analysis among 300000 Norwegian women

Idlir Licaj, Bjarne Koster Jacobsen, Randi Marie Selmer, Gertraud Maskarinec, Elisabete Weiderpass and Inger Torhild Gram

Br J Cancer 2017 116: 270-276; advance online publication, December 13, 2016; 10.1038/bjc.2016.418

Abstract | Full Text

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: